Immunomedics Discovers Potential New Therapy for Graft-Versus-Host Disease
MORRIS PLAINS, N.J. — Immunomedics, Inc. , a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other …
